Host immune classifier HIC assays may predict treatment response
Morocco starts vaccinating medics en masse against virus
30 January 2021Iran expects first batch of Russian vaccine by Feb 4
30 January 2021Host immune classifier HIC assays may predict treatment response
Using a host immune classifier (HIC) test for patients with non-small cell lung cancer (NSCLC) may provide better predictors of treatment response and improve outcomes, according to research presented today at the International Association for the Study of Lung Cancer’s 2020 World Conference on Lung Cancer Singapore.
